Medicus IT Announces Supplier Agreement with EyeProGPO to Enhance Services Reach

Medicus IT (“Medicus” or “the Company”), the leading healthcare-focused IT managed services provider, today announced that it has signed a strategic supplier agreement with EyeProGPO to significantly enhance its services reach across the nation within the ophthalmology segment. This collaboration aligns the shared mission of both organizations to improve patient outcomes through innovative, scalable, and secure IT solutions.

Through this partnership, Medicus IT, already a leader in the ophthalmology space and renowned for aiding ophthalmology practices nationwide with cutting-edge technology tailored to the needs of providers, patients, and staff, will expand its reach to over 1100 members of EyeProGPO. This expansion further solidifies Medicus’ position as the premier IT solutions provider dedicated to healthcare and the unique complexities of maintaining secure IT environments.

EyeProGPO members will now benefit from exclusive access to Medicus’ suite of comprehensive services and competitive pricing, enhancing their operational efficiency and patient care quality. Additionally, members will gain insights into leveraging IT for optimized practice operations, leading to cost savings and improved patient satisfaction.

“This partnership marks a significant milestone for Medicus and its membership in specialty-focused GPOs,” said Daniel Livschutz, Senior Vice President of Business Development, Medicus IT. “By leveraging the extensive network of EyeProGPO, we are positioned as the healthcare IT solutions partner of choice within their membership group. This allows us to reach over 1,100 eye care facilities with technology solutions designed to foster growth and improve patient outcomes. We’re also excited to provide an opportunity for our customers to learn more about the savings and efficiency EyeProGPO brings to their healthcare organizations. This partnership allows both organizations to continue winning together.”

Medicus IT is such a great fit for EyeProGPO. We are steadfast in our commitment to offer our members unrivaled value and savings. Through this new partnership, we’re ensuring that our members have access to the best IT services and support on the market. We believe our combined strengths will increase value for healthcare providers across the nation,” says Phil Meyer, COO of EyeProGPO.

This agreement underscores Medicus’ unwavering commitment to fostering alliances that drive innovation and growth in the healthcare industry. As we continue to expand our capabilities, we remain dedicated to enabling healthcare providers to focus on their patients by ensuring their IT infrastructure is secure, efficient, and scalable.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”